Cbay stock price.

3 days ago ... Latest CBAY News along with Price and Volume Analysis CBAY Stock Analysis $CBAY Latest News TickerDD. 1 view · 3 minutes ago ...more. TickerDD.Jun 30, 2023 · What happened. Shares of CymaBay Therapeutics ( CBAY -0.06%) were up more than 37% as of 11:15 a.m. ET on Friday. The clinical-stage biotech saw its shares rise after Ipsen and Genfit announced ... Oct 15, 2020 · About the CymaBay Therapeutics, Inc. stock forecast. As of 2024 January 16, Tuesday current price of CBAY stock is 23.760$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Cymabay Therapeutics stock price as been showing a rising tendency so we believe that similar market …At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

BETS. Bit Brother Limited Class A Ordinary Shares. $6.63 +0.83 +14.31%. CymaBay Therapeutics Inc. Common Stock (CBAY) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data ...

Shares of the Newark, California-based drug developer jumped 24.6% to a record high of $32.01 in morning trading on Monday, compared to the offer price of $32.50 per share. Gilead's shares rose 1. ...

If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t...Nov 8, 2023 · CymaBay Therapeutics Inc. (CBAY) closed the last trading session at $16.44, gaining 15.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price ...Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing.Find out the latest stock price, news, and analysis of eBay Inc (EBAY) on Google Finance, the best source for financial information on the web.

What this means: CymaBay Therapeutics Inc. (CBAY) gets an Overall Rank of 68, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.

Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.

Get CymaBay Therapeutics Inc (CBAY.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsCymaBay Therapeutics (CBAY) CymaBay Therapeutics received a Hold rating and a $32.50 price target from H.C. Wainwright analyst Ed Arce today. The company’s shares closed last Monday at $32.21 ...Feb 16, 2024 · CBAY, CymaBay Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines CymaBay Therapeutics (CBAY) Options Chain & Prices. $25.69. +0.73 (+2.92%) (As of 02/9/2024 ET) Compare. Share. Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media Sustainability.Mar 9, 2021 · The CymaBay Therapeutics, Inc. stock price is closed at $ 23.09 with a total market cap valuation of $ 2.62B ( 113.40M shares outstanding). The CymaBay Therapeutics, Inc. is trading on NASDAQ with the sign CBAY. CymaBay Therapeutics, Inc. price is up 3.92% in the past 24 hours. The CymaBay Therapeutics, Inc. stock price prediction is …Shortly after the Monday announcement, CymaBay said that the Food and Drug Administration had accepted its application for approval of seladelpar, and that it would issue a decision in August. Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.

CBAY is trading at a 1% premium. Price $23.84 Feb 2, 2024 Fair Value $67.78 Feb 2, 2024 Uncertainty Very High 1-Star Price $25.73NEWARK, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company …TradingView India. View live CymaBay Therapeutics Inc. chart to track its stock's price action. Find market predictions, CBAY financials and market news.CymaBay Therapeutics Inc. (CBAY) closed the last trading session at $16.44, gaining 15.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price ...CBAY, for $32.50 per share in cash or a total equity value of $4.3 billion. Shares of CBAY surged on the acquisition news as the offer price represents 27% of the …

CymaBay Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ... Stock Price Target CBAY. High $ 36.00: Median $ 28.00: Low $ 20.00: Average $ 28.42: Current ... You can buy or sell CBAY and other ETFs, options, and stocks. View the real-time CBAY price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. See Robinhood Financial’s fee schedule at rbnhd ...

Nov 8, 2023 · CymaBay Therapeutics Inc. (CBAY) closed the last trading session at $16.44, gaining 15.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price ...The CymaBay Therapeutics stock price forecast for the next 30 days is a projection based on the positive/negative trends in the past 30 days. Based on the current trend the price of CBAY stock is predicted to drop by -2.56% tomorrow and lose -2.59% in the next 7 days. VinFast Auto Ltd. Ordinary Shares. $17.15 -0.84 -4.67%. CymaBay Therapeutics Inc. Common Stock (CBAY) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data ... A solid price increase over a period of 12 weeks reflects investors' continued willingness to pay more for the potential upside in a stock. CBAY is quite a good fit in this regard, gaining 20.6% ...BETS. Bit Brother Limited Class A Ordinary Shares. $6.63 +0.83 +14.31%. CymaBay Therapeutics Inc. Common Stock (CBAY) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data ... CBAY stock jumped 3.5% the day Genfit and Ipsen reported these results on Nov. 13. Genfit shares eked out a fractional gain. ... Realtime quote and/or trade prices are not sourced from all markets. CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce ...

Real time CymaBay Therapeutics (CBAY) stock price quote, stock graph, news & analysis.

CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce ...

According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference betwe...Feb 12, 2024 ... ... price Friday. CymaBay shares skyrocketed Monday to an all-time high after the news. Shares of CymaBay Therapeutics (CBAY) ...Feb 15, 2024 · (CBAY Quick Quote CBAY - Free Report) , for $32.50 per share in cash or a total equity value of $4.3 billion. Shares of CBAY surged on the acquisition news as the offer price represents 27% of the ... Cymabay Therapeu Market Momentum ; Rate Of Daily Change, 1.0 ; Day Median Price, 32.22 ; Day Typical Price, 32.22 ; Market Facilitation Index, 0.08 ; Price Action ...TradingView India. View live CymaBay Therapeutics Inc. chart to track its stock's price action. Find market predictions, CBAY financials and market news.Nov 11, 2023 · CymaBay Therapeutics (NASDAQ:CBAY) rose ~11% on Friday as the company prepares to update results from its Phase 3 RESPONSE study for liver disease therapy seladelpar at a medical event in Boston, MA.Jan 30, 2024 · Headquarters. CymaBay Therapeutics 7575 Gateway Blvd Suite 110 Newark, CA 94560 T: (510) 293-8800NEWARK, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ... CymaBay Therapeutics Insider Sold Shares Worth $435,645, According to a Recent SEC Filing. Jan. 23. MT. Transcript : CymaBay Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 04:30 PM. 5 days ago · According to the issued ratings of 13 analysts in the last year, the consensus rating for CymaBay Therapeutics stock is Hold based on the current 11 hold ratings and 2 buy ratings for CBAY. The average twelve-month price prediction for CymaBay Therapeutics is $26.73 with a high price target of $32.50 and a low price target of $12.00. 3 days ago ... Latest CBAY News along with Price and Volume Analysis CBAY Stock Analysis $CBAY Latest News TickerDD. 1 view · 3 minutes ago ...more. TickerDD.

Feb 7, 2024 · CBAY News. 6 days ago - CymaBay Therapeutics to Participate in Upcoming Investment Conferences - GlobeNewsWire 20 days ago - CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire 4 weeks ago - New Published Data Demonstrates Correlation Between Itch Cytokine Interleukin-31 …CBAY has fallen -$0.10 from the previous closing price of $22.85 on volume of 483,390 shares. Over the past year the S&P 500 has gained 21.52% while CBAY has gained 191.67%. CBAY lost -$0.93 per share the over the last 12 months. Click Here to get the full Stock Report for CymaBay Therapeutics Inc stock.Feb 18, 2024 · Summary of all time highs, changes and price drops for CymaBay Therapeutics; Historical stock prices; Current Share Price: US$32.19: 52 Week High: US$32.24 Instagram:https://instagram. golden corral buffet prices 2023mr telephone mancheap flights to europe from bostonwe work near me CymaBay Therapeutics Inc. (CBAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move. spanish mappinghomebase near me Cymabay Therapeutics (CBAY) Stock Price Performance. Cymabay Therapeutics (CBAY) Stock Key Data ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months. This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price last Friday. Gilead Sciences is acquiring CymaBay for its lead product candidate, seladelpar. This is a treatment in development to treat primary biliary cholangitis (PBC). Gilead Sciences … chase comverify card Feb 16, 2024 · Their CBAY share price targets range from $12.00 to $32.50. On average, they predict the company's share price to reach $26.15 in the next year. This suggests that the stock has a possible downside of 18.7%. View analysts price targets for CBAY or view top-rated stocks among Wall Street analysts. CBAY is trading at a 1% premium. Price $23.84 Feb 2, 2024 Fair Value $67.78 Feb 2, 2024 Uncertainty Very High 1-Star Price $25.73CBAY ranks lowest in Stability; there it ranks in the 2nd percentile. CBAY Stock Summary. The capital turnover (annual revenue relative to shareholder's equity) for CBAY is 0.1 -- better than just 13.13% of US stocks. With a price/sales ratio of 84.02, CYMABAY THERAPEUTICS INC has a higher such ratio than 97.51% of stocks in our set.